对帕金森病的病原发生的图书统计分析
Yuan Feng1, Kaixiao Wang2, Xulong Guo1
1Southern Medical University, 1023 South Shatai Road, Baiyun District, Guangzhou, Guangdong 510515, China.
Pathology, research and practice
|February 24, 2026
概括
关于帕金森病病原学的研究正在迅速扩大,揭示了新的趋势. 关键领域包括肠-大脑轴和ferroptosis,将重点转移到系统机制,而不是孤立的途径.
科学领域:
- 神经科学是一个神经科学.
- 生物医学研究生物医学研究
- 遗传学 是一个遗传学.
背景情况:
- 帕金森病 (PD) 病原研究在2015-2024年期间出现了显著的增长.
- 这项研究为研究人员提供了关于进展和趋势的全面概述.
研究的目的:
- 分析和可视化全球研究趋势和帕金森病病源的热点.
- 提供对新兴机制和未来研究方向的见解.
主要方法:
- 来自Web of Science核心集合 (2015-2024) 的3140篇文章的图书统计分析.
- 使用CiteSpace和VOSviewer进行数据可视化和分析.
- 关键词同时出现的分析,以确定研究热点.
主要成果:
- 自2015年以来,出版物出现了显著的上升趋势,中国,美国和意大利是最大的贡献者.
- 关键的研究热点包括α-synuclein聚合,线粒体功能障碍,神经炎症和自-溶酶体系统.
- 新兴趋势突出显示了肠-大脑轴和铁亡,表明向系统机制的转变.
结论:
- 帕金森病的发病因子研究正在全球获得大量关注.
- 图书统计分析揭示了关键趋势和热点,为未来的PD机制研究提供了有价值的观点.
相关概念视频
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Lysosomal Hydrolases
4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
2.2K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.2K
Neural Regulation
43.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.7K
The Proteasome
10.4K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.4K


